Wednesday, January 14, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home AI & Quantum Computing

Palantir Stock: A Clash of Titans Between a Legendary Short Seller and Its CEO

Dieter Jaworski by Dieter Jaworski
November 30, 2025
in AI & Quantum Computing, Analysis, Nasdaq, Tech & Software, Trading & Momentum
0
Palantir Stock
0
SHARES
29
VIEWS
Share on FacebookShare on Twitter

The meteoric rise of Palantir Technologies Inc. throughout the year is undeniable, but a significant challenge has now emerged. Michael Burry, the famed investor immortalized in “The Big Short,” has placed a massive bet against the artificial intelligence leader. His firm has established a short position valued at hundreds of millions of dollars, anticipating a substantial decline in the share price. This bearish stance, however, is being directly countered by a surprising and confident move from Palantir’s own Chief Executive Officer, Alex Karp. The financial markets are now watching closely to see which of these powerful figures will prevail in this high-stakes confrontation.

CEO Confidence Confronts the Bears

From the company’s leadership comes a powerful signal intended to bolster investor confidence. Alex Karp has decided to terminate his pre-arranged stock trading plan, known as a 10b5-1 plan. Historically, executives use these plans to systematically sell shares. By halting his automatic sales instead of renewing the program, Karp is sending a strong message to the market. This action demonstrates a belief within the upper management that the company’s stock possesses further upside potential, while simultaneously removing a source of consistent selling pressure that often weighs on a share price.

This vote of confidence from the top is supported by robust operational performance. The company’s most recent quarterly earnings surpassed market expectations. A particularly stunning figure was the 121 percent explosion in commercial revenue within the United States, a surge largely credited to the rapid adoption of its proprietary Artificial Intelligence Platform (AIP).

The Valuation Concern Driving the Short Bet

The primary catalyst for Michael Burry’s substantial bearish wager is a fundamental concern over valuation. Scion Asset Management, his investment firm, has disclosed put options against Palantir with a notional value of $900 million. The core of this investment thesis hinges on the belief that the stock has become excessively overvalued.

Should investors sell immediately? Or is it worth buying Palantir?

To conservative investors, the metrics are indeed startling. The stock trades at a price-to-earnings multiple approaching 400 and a price-to-sales multiple exceeding 60. Burry is effectively betting that the current market euphoria will dissipate, forcing a sharp correction that realigns the share price with its fundamental financials. Market action already reflects this tension; the stock has retreated approximately 20 percent from its 52-week high of around 180 Euros.

Strategic Wins and Government Uncertainties

Beyond the stock market battle, Palantir’s business landscape presents a mixed picture. In Europe, the company secured a monumental strategic partnership with the UK Ministry of Defence. This agreement paves the way for investments that could reach up to £1.5 billion over the coming decade, representing a huge vote of confidence and a significant revenue stream.

Conversely, in its key domestic market, a cloud of uncertainty has formed. The Pentagon has initiated a review of its software budgeting, which includes the potential for reallocating funds. While Palantir has not been explicitly singled out, this situation creates nervousness among institutional investors. The competition for lucrative government contracts between established defense contractors and disruptive AI-focused firms like Palantir introduces a element of short-term risk.

The Palantir stock narrative has become a classic battleground, pitting fears of an inflated valuation against aggressive growth expectations. The central question for investors is whether the demonstrative confidence from CEO Alex Karp will be enough to stabilize and rally the shares, or if Michael Burry’s pessimistic outlook will ultimately triumph.

Ad

Palantir Stock: Buy or Sell?! New Palantir Analysis from January 14 delivers the answer:

The latest Palantir figures speak for themselves: Urgent action needed for Palantir investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from January 14.

Palantir: Buy or sell? Read more here...

Tags: Palantir
Dieter Jaworski

Dieter Jaworski

About Dieter Jaworski From a numbers-obsessed child to creating his first investment newsletter. Even as a child, Dieter Jaworski's mother couldn't believe how fascinated he was with numbers. This early passion for mathematics and data analysis laid the foundation for a successful career in financial markets and investment analysis.
Areas of Expertise:
  • Quantitative Analysis
  • Financial Newsletter Publishing
  • Data-Driven Investment Strategies
  • Market Pattern Recognition
Dieter's unique approach combines his natural affinity for numbers with decades of market experience, providing investors with data-driven insights and practical investment strategies.

Related Posts

CureVac Stock
Mergers & Acquisitions

CureVac’s Stock Market Journey Concludes Following BioNTech Acquisition

January 14, 2026
Micron Stock
Analysis

Micron Stock Receives Major Analyst Upgrades Amid AI Demand Surge

January 14, 2026
Almonty Stock
Analysis

Almonty Industries Enters New Phase Following Monumental Share Price Surge

January 14, 2026
Next Post
Rigetti Stock

A Contrarian Bet on Quantum Computing

Rocket Lab USA Stock

Rocket Lab USA: A Surge in Operations Contrasts with Insider Selling Spree

IREN Stock

IREN Stock: From Bitcoin Mining to AI Powerhouse in One Transformative Deal

Recommended

BioNTech Stock

BioNTech Stock: Mixed Signals Amid Cancer Push

5 months ago
Vital Farms Stock

Vital Farms Shares Face Headwinds Amid Forecast Revisions and Insider Activity

3 days ago
Bitcoin Stock

The Institutional Floodgates Open: Vanguard’s Crypto Reversal Ignites Bitcoin Rally

1 month ago
Technology Data analytics stock Trading (1)

Introducing StarCoder2 A Revolutionary Collaboration in OpenAccess Large Language Models for Code Generation

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Goldman Sachs Initiates Coverage on NetApp with Bullish Outlook

Parker-Hannifin Shares Attract Bullish Price Target Revisions

FactSet Research: Strong Earnings Fail to Convince Skeptical Analyst

Amazon Appeals Italian Antitrust Ruling Despite Fine Reduction

Rigetti Revises Quantum Computing Timeline, Prioritizing System Performance

Uranium Energy Capitalizes on Market Dynamics with Strategic Expansion

Trending

CureVac Stock
Mergers & Acquisitions

CureVac’s Stock Market Journey Concludes Following BioNTech Acquisition

by Andreas Sommer
January 14, 2026
0

The final chapter for Tübingen-based mRNA pioneer CureVac on public markets is now written. A turbulent period...

Micron Stock

Micron Stock Receives Major Analyst Upgrades Amid AI Demand Surge

January 14, 2026
Almonty Stock

Almonty Industries Enters New Phase Following Monumental Share Price Surge

January 14, 2026
NetApp Stock

Goldman Sachs Initiates Coverage on NetApp with Bullish Outlook

January 14, 2026
Parker-Hannifin Stock

Parker-Hannifin Shares Attract Bullish Price Target Revisions

January 14, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • CureVac’s Stock Market Journey Concludes Following BioNTech Acquisition
  • Micron Stock Receives Major Analyst Upgrades Amid AI Demand Surge
  • Almonty Industries Enters New Phase Following Monumental Share Price Surge

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com